These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 35884574)

  • 1. Inflammation-Driven Regulation of PD-L1 and PD-L2, and Their Cross-Interactions with Protective Soluble TNFα Receptors in Human Triple-Negative Breast Cancer.
    Baram T; Oren N; Erlichman N; Meshel T; Ben-Baruch A
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
    Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
    Front Immunol; 2019; 10():804. PubMed ID: 31105691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer.
    Liubomirski Y; Lerrer S; Meshel T; Rubinstein-Achiasaf L; Morein D; Wiemann S; Körner C; Ben-Baruch A
    Front Immunol; 2019; 10():757. PubMed ID: 31031757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines.
    Lotfinejad P; Kazemi T; Safaei S; Amini M; Roshani Asl E; Baghbani E; Sandoghchian Shotorbani S; Jadidi Niaragh F; Derakhshani A; Abdoli Shadbad M; Silvestris N; Baradaran B
    Biomed Pharmacother; 2021 Jun; 138():111436. PubMed ID: 33667790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Breast Cancer Are Regulated by N-Linked Glycosylation-Dependent Activation of STAT3 and STAT1.
    Erlichman N; Meshel T; Baram T; Abu Raiya A; Horvitz T; Ben-Yaakov H; Ben-Baruch A
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
    Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
    J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous Inflammatory Stimulation Leads via Metabolic Plasticity to a Prometastatic Phenotype in Triple-Negative Breast Cancer Cells.
    Morein D; Rubinstein-Achiasaf L; Brayer H; Dorot O; Pichinuk E; Ben-Yaakov H; Meshel T; Pasmanik-Chor M; Ben-Baruch A
    Cells; 2021 May; 10(6):. PubMed ID: 34072893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon nanotubes (CNT)-loaded ginsenosides Rb3 suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer.
    Luo X; Wang H; Ji D
    Aging (Albany NY); 2021 Jun; 13(13):17177-17189. PubMed ID: 34111025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes.
    Erlichman N; Baram T; Meshel T; Morein D; Da'adoosh B; Ben-Baruch A
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition.
    Soria G; Ofri-Shahak M; Haas I; Yaal-Hahoshen N; Leider-Trejo L; Leibovich-Rivkin T; Weitzenfeld P; Meshel T; Shabtai E; Gutman M; Ben-Baruch A
    BMC Cancer; 2011 Apr; 11():130. PubMed ID: 21486440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer.
    Tian Y; Sun X; Cheng G; Ji E; Yang S; Feng J; Zheng L
    Ann Transl Med; 2021 Jan; 9(2):131. PubMed ID: 33569433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability of the tumor necrosis factor alpha/regulated on activation, normal T cell expressed and secreted (RANTES) biosystem inside the gestational sac during the pre-immune stages of embryo development.
    Santolaya JL; Schweer DS; Cardenas-Goicoechea J; Bukowski R; Santolaya-Forgas J
    J Perinat Med; 2023 Sep; 51(7):891-895. PubMed ID: 37067543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GBP5 Repression Suppresses the Metastatic Potential and PD-L1 Expression in Triple-Negative Breast Cancer.
    Cheng SW; Chen PC; Lin MH; Ger TR; Chiu HW; Lin YF
    Biomedicines; 2021 Apr; 9(4):. PubMed ID: 33916322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer.
    Chen M; Pockaj B; Andreozzi M; Barrett MT; Krishna S; Eaton S; Niu R; Anderson KS
    Clin Breast Cancer; 2018 Oct; 18(5):e1205-e1215. PubMed ID: 29933930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery.
    Shadbad MA; Safaei S; Brunetti O; Derakhshani A; Lotfinejad P; Mokhtarzadeh A; Hemmat N; Racanelli V; Solimando AG; Argentiero A; Silvestris N; Baradaran B
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of indoximod upon stimulation with pro-inflammatory cytokines in triple-negative breast cancer cells.
    Guney Eskiler G; Bilir C
    Immunopharmacol Immunotoxicol; 2021 Oct; 43(5):554-561. PubMed ID: 34314307
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Hirayama A; Ishigaki H; Takahashi K; Miura Y; Kikuchi H; Kubohara Y
    Juntendo Iji Zasshi; 2023; 69(2):105-115. PubMed ID: 38854456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bovine tumor necrosis factor alpha decoy receptors on cell death and inflammatory cytokine kinetics: potential for bovine inflammation therapy.
    Fujisawa S; Konnai S; Okagawa T; Maekawa N; Tanaka A; Suzuki Y; Murata S; Ohashi K
    BMC Vet Res; 2019 Feb; 15(1):68. PubMed ID: 30819151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFNγ, and to a Lesser Extent TNFα, Provokes a Sustained Endothelial Costimulatory Phenotype.
    Valenzuela NM
    Front Immunol; 2021; 12():648946. PubMed ID: 33936069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.